BEAT
HeartBeam, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.43
+1.31%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.8x
Market Cap
$23.98M
MomentumView details →
1D Return
+1.31%
YTD Return
−82.65%
RSI (14)
31.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.8x
Market Cap
$23.98M
RSI (14)
31.1
MomentumView details →
1D Return
+1.31%
YTD Return
−82.65%
SummaryUpdated Jun 1, 2026
HeartBeam, Inc. (NASDAQ:BEAT) is a medical technology company founded in 2015 and headquartered in Santa Clara, California. The company went public in November 2021 and focuses on developing innovative telemedicine solutions for cardiac monitoring and diagnosis outside traditional healthcare facility settings. HeartBeam has developed proprietary technology that enables the creation of a credit card-sized, cable-free electrocardiogram (ECG) device capable of synthesizing a full 12-lead ECG reading, representing a significant advancement in portable cardiac monitoring technology.
Similar companies
Latest newsMore news →
HeartBeam, Inc. held its Q2 2026 earnings call on August 14, 2026.22d agoHeartBeam, Inc. signed an at-the-market equity offering sales agreement with Titan Partners Securities LLC, allowing HeartBeam to sell up to $25,000,000 of its common stock from time to time, with Titan Partners receiving a commission of up to 3% of gross sales price.22d ago